Table 1

Clinical (A) and CMR (B) baseline characteristics.

(A) ClinicalAll patients (n=91)
Age (years)49.9±16.8
Male (%)69 (76)
BSA (m2)1.92±0.2
Family history of HCM, n(%)32 (35)
 Diabetes, n(%)5 (5)
 Hypertension, n(%)27 (30)
 Hypercholesterolaemia, n(%)22 (24)
 Renal insufficiency
 (GFR <60 mL/min), n(%)
9 (10)
 CAD, n(%)0 (0)
 Class NYHA III-IV n(%)12 (13)
(B) CMRAll patientsHOCMHNCMP value
LVEF (%)65.3±8.667.0±6.563.6±10.00.116
IVS (mm)19.6±4.020.9±3.618.3±3.9<0.001
LVMi (g/m2)85.0±29.690.8±29.479.3±29.40.032
LVEDVi (mL)74.8±16.375.1±14.874.4±17.90.520
T2* (ms)26.5±4.625.5±4.027.4±4.90.055
  • BSA, body surface area; CAD, coronary artery diseases; CMR, cardiovascular magnetic resonance; GFR, glomerular filtration rate; HCM, hypertrophic cardiomyopathy; HNCM, hypertrophic non-obstructive cardiomyopathy; HOCM, hypertrophic obstructive cardiomyopathy; IVS, interventricular septum; LVEDVi, left ventricular indexed end-diastolic volume; LVEF, left ventricular ejection fraction; LVMi, left ventricular indexed mass; NYHA, New York Heart Association.